Sophie Campagno

Part of MEDIAN Technologies SA, Median Technologies, Inc. provides medical imaging services. The company is based in Burlington, MA. The CEO of the company is Fredrik Bjjorn Brag.

Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD.

Scorpion Therapeutics, Inc. provides health care services. The company is headquartered in Boston, MA.

BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA.

Direct Conversion AB manufactures and supplies X-Ray detectors such as cadmium telluride (CdTe) detectors. Its products include XC-THOR, XC-HYDRA, XC-TDI, XC-ACTAEON, SNAP 225, SNAP 150 and SNAP 100X2. The firm’s products are used in the dental, medical, welding, industrial, food and security industries. The company was founded in 1997 and is headquartered in Danderyd, Sweden.

Isocell SA operates as a holding company with interests in the manufacture of food supplements. It develops proprietary formulation for super-oxyde dismutase. The firm also targets food areas including sodas, sport drinks and dairies with wellness claims. It also engages in the ownership and operations of medical laboratories. The company was founded by Francois Vix on July 9, 2001 and is headquartered in Paris, France.

eXo Platform SAS provides information technology products and services. Its offers private cloud hosting, professional services, on-demand services, services packages, and training. The company was founded by Benjamin Mestrallet in 2003 and is headquartered in Paris, France.

Convertigo SAS provides Internet related software. It delivers a secured and scalable disruptive all-in-one solution, integrating rapid cross platform mobile development tools and a powerful MBaaS covering challenging backend enablement, featuring a middleware optimized for mobility. The company was founded by Olivier Picciotto and Jean-Michel Cohen in 1994 and is headquartered in Orsay, France.

iDbyMe SA sells clothes online. It provides online shopping related services. The firm offers sweaters, short cardigans, long and short vests, shirts, leather jackets, tops, dresses and coats. It provides to its customers the possibility to submit their own clothing designs. The company is headquartered in Luxembourg.

Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France.

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Fabentech SAS developes immunotherapeutic solutions for emerging infectious diseases as well as for certain drug intoxications. Its products include infography development, Lassa(FBH-003) and other emerging diseases. The company was founded by Bertrand Lepine on June 5, 2009 and is headquartered in Lyon, France.

Firalis SA engages in the discovery and development of biomarker-based diagnostics. It offers biomarkers for drug safety, cardiovascular, inflammatory and autoimmune diseases. The firm offers a portfolio of biomarker-based diagnostic methods and provides customer-tailored biomarker solutions. The company was founded on July 8, 2008 by Hüseyin Firat and is headquartered in Huningue, France.

BonitaSoft SA develops open source software. It also provides open source business process management solutions. The firm's product, Bonita open solution, is an open source BPM solution that designs, develops, executes, and monitors business processes; Bonita Studio, a BPM notation solution for drawing processes graphically; and Bonita execution engine with Bonita open solution for integrating new services or BPM standards as they emerge. The company was founded by Rodrigue Le Gall, Charles Souillard, and Miguel Valdes-Faura in 2001 and is headquartered in Boulogne, France.

Elaia Partners SAS (Elaia) is an independent French private equity boutique which was founded in 2002. Named after the Greek word for olive tree, the symbol of resilience, longevity and prosperity, Elaia focuses on software technology companies. The firm is headquartered in Paris and manages Elaia Ventures, a French FCPR fund backed by financial institutions, industrial investors and family offices.

Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France.

Pylote SA conceives and develops mineral microspheres to sell solutions. Its products include mineral microspheres, material integration and pylote added. The company was founded by Loïc Marchin and is headquartered in Dremil-Lafage, France.

EnobraQ SAS develops yeast for the production of chemical compounds. The company was founded on November 13, 2015 and is headquartered in Ramonville-Saint-Agne, France.

Flash Therapeutics SAS provides biotechnology products for medical research. It custom products include lentiviral vectors, non-integrating lentiviral vectors, stable cell line and animal models. The company was founded by Pascale Bouill? in 2005 and is headquartered in Toulouse, France.

Alesi Surgical Ltd. is a holding company, which engages in the manufacture and development of medical devices. It focuses on minimally invasive surgery. Alesi works with surgeons to identify, resolve issues and develops techniques for the healthcare provider. Its Ultravision is a revolutionary new system that clears surgical smoke from the visual field and prevents its release into the operating theatre during laparoscopic surgery. The company was founded by Neil Warren in 2009 and is headquartered in Cardiff, the United Kingdom.

Availpro SAS provides online hotel reservation solutions. It offers a booking engine, which is integrated with a distribution tool, allowing the hoteliers to advertise and sell their rooms on third party websites. The company was founded by Philippe Jean Pierre Lamarche and Sébastien Maurice Boher on April 6, 2001 and is headquartered in Paris, France.

Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY.

AlpInvest Partners BV (AlpInvest) is a private equity asset subsidiary AP BV, ultimately owned by The Carlyle Group, Inc founded in 2000. AlpInvest Partners BV is headquartered in Amsterdam, the Netherlands.

Andrew Alliance SA develops liquid handling solutions. Its product, Andrew, is a novel liquid handling robot designed for pipetting process. The firm's products include Andrew models, consumable dominos, protocol design, and enabling accessories. The company was founded by Piero Zucchelli, Giorgio Horak, and Antoine Jordan in March 2011 and is headquartered in Vernier, Switzerland.

Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.